ImmunityBio

IBRX

Börsenwert 8,71 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Wildcat Capital Management New York	34,9 Mio. $	-74.716 $	-10.000	-0,2 %
2	2 Callan Capital La Jolla, California	26,5 Mio. $	-2,66 Mio. $	-356.681	-9 %
3	3 Capital Research Global Investors Los Angeles, California	20,7 Mio. $	–	–	–
4	4 Fidelity Investments Boston, Massachusetts	16,8 Mio. $	-863.956 $	-115.632	-5 %
5	5 Vanguard Group Malvern, Pennsylvania	14,3 Mio. $	+1,87 Mio. $	+250.878	+16 %
6	6 BlackRock Fund Advisors San Francisco, California	11,9 Mio. $	+622.347 $	+83.295	+6 %
7	7 Franklin Resources San Mateo, California	8,1 Mio. $	–	–	–
8	8 Bank of America Charlotte, North Carolina	3,85 Mio. $	+62.933 $	+8.423	+2 %
9	9 BlackRock Institutional Trust San Francisco, California	2,56 Mio. $	+630.080 $	+84.330	+34 %
10	10 Geode Capital Management Boston, Massachusetts	1,8 Mio. $	+990.928 $	+132.626	+134 %
11	AG 11 Artal Group Luxembourg	1,75 Mio. $	–	–	–
12	12 Northern Trust Chicago, Illinois	1,42 Mio. $	+208.839 $	+27.951	+18 %
13	13 State Street Boston, Massachusetts	1,19 Mio. $	+129.505 $	+17.333	+13 %
14	14 JP Morgan Chase New York	1,11 Mio. $	-44.815 $	-5.998	-4 %
15	15 Vident Investment Advisory Alpharetta, Georgia	792.000 $	-4.879 $	-653	-0,6 %
16	16 Bank of New York Mellon New York	666.000 $	+52.481 $	+7.024	+9 %
17	17 Avoro Capital Advisors New York	563.000 $	–	–	–
18	18 Charles Schwab San Francisco, California	557.000 $	+237.866 $	+31.836	+80 %
19	19 BlackRock Investment Management Wilmington, Delaware	496.000 $	-1.061 $	-142	-0,2 %
20	20 ProShare Advisors Bethesda, Maryland	417.000 $	-71.122 $	-9.519	-15 %
21	21 TIAA CREF Investment Management New York	377.000 $	+11.715 $	+1.568	+3 %
22	22 Swiss National Bank Zurich, Switzerland	330.000 $	–	–	–
23	23 Virtus ETF Advisers New York	295.000 $	–	–	–
24	24 California State Teachers Retirement System (CalSTRS) West Sacramento, California	274.000 $	+2.241 $	+300	+0,9 %
25	25 AllianceBernstein Nashville, Tennessee	242.000 $	+18.679 $	+2.500	+9 %

ImmunityBio IBRX Börsenwert 8,71 Mrd. $

ImmunityBio

IBRX

Börsenwert 8,71 Mrd. $